Ribometrix
Latest round
- Series A
Last raised
- Nov 2018
Total raised
- $38M
Investors
- 10
About Ribometrix
Ribometrix, Inc.Founded in 2014 and headquartered in Durham, US, Ribometrix, Inc. develops small molecule drugs that modulate cellular RNAs.80 mn occurring on August 1, 2022.Ribometrix focuses on developing innovative small molecule drugs that target and modulate cellular RNAs, which play a crucial role in the production of disease-causing proteins. Their primary offerings leverage a unique approach by correcting protein production through specific interactions with structural and functional "hot spots" in encoding mRNA. This can involve selective binding or the incorporation of engineered RNA-degrading components for situations where binding alone is insufficient. Ribometrix aims to address a variety of diseases across multiple therapeutic areas, appealing to a diverse client base that includes pharmaceutical companies and research institutions.Revenue generation for Ribometrix is structured through strategic partnerships and collaborations within the biopharmaceutical industry, focusing primarily on B2B transactions. These partnerships involve co-development agreements and research collaborations with pharmaceutical companies looking to leverage Ribometrix's RNA-targeting technology in their therapeutic pipelines. The financial arrangements typically include milestone payments and royalties tied to the successful development and commercialization of therapeutics derived from their proprietary platforms.As of the most recent deal in Q3 2022, Ribometrix, Inc. This strategic focus indicates a commitment to increasing its global footprint and developing innovative solutions in the biopharmaceutical landscape.
Who invested in Ribometrix
10 investors across 2 rounds
See all investors in Ribometrix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ribometrix
Who invested in Ribometrix?
Ribometrix has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ribometrix raised?
Ribometrix has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ribometrix last raise money?
Ribometrix's most recent round on record is a Series A, in Nov 2018.
What does Ribometrix do?
Ribometrix is a pharmaceuticals company.
Where is Ribometrix headquartered?
Ribometrix is headquartered in Durham, US.
Which VCs invest in companies like Ribometrix?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Ribometrix's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Ribometrix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.